Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

659 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.
Macdougall IC, Rossert J, Casadevall N, Stead RB, Duliege AM, Froissart M, Eckardt KU. Macdougall IC, et al. Among authors: eckardt ku. N Engl J Med. 2009 Nov 5;361(19):1848-55. doi: 10.1056/NEJMoa074037. N Engl J Med. 2009. PMID: 19890127 Free article. Clinical Trial.
Hemoglobin variability does not predict mortality in European hemodialysis patients.
Eckardt KU, Kim J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, Fouqueray B, Macdougall IC. Eckardt KU, et al. J Am Soc Nephrol. 2010 Oct;21(10):1765-75. doi: 10.1681/ASN.2009101017. Epub 2010 Aug 26. J Am Soc Nephrol. 2010. PMID: 20798262 Free PMC article.
Value of N-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: results from the CREATE study.
Locatelli F, Eckardt KU, Macdougall IC, Tsakiris D, Clyne N, Burger HU, Scherhag A, Drüeke TB; Cardiovascular Risk Reduction in Early Anaemia Trial with Epoetin Beta investigators and coordinators. Locatelli F, et al. Among authors: eckardt ku. Curr Med Res Opin. 2010 Nov;26(11):2543-52. doi: 10.1185/03007995.2010.516237. Epub 2010 Sep 17. Curr Med Res Opin. 2010. PMID: 20849244 Clinical Trial.
The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale.
Macdougall IC, Bock A, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Cushway T, Roger SD; FIND-CKD Study Investigators. Macdougall IC, et al. Among authors: eckardt ku. Nephrol Dial Transplant. 2014 Apr;29(4):843-50. doi: 10.1093/ndt/gft424. Epub 2013 Oct 29. Nephrol Dial Transplant. 2014. PMID: 24170814 Free PMC article. Clinical Trial.
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.
Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Nolen JG, Roger SD; FIND-CKD Study Investigators. Macdougall IC, et al. Among authors: eckardt ku. Nephrol Dial Transplant. 2014 Nov;29(11):2075-84. doi: 10.1093/ndt/gfu201. Epub 2014 Jun 2. Nephrol Dial Transplant. 2014. PMID: 24891437 Free PMC article. Clinical Trial.
659 results